Psyence Biomedical Statistics
Total Valuation
PBM has a market cap or net worth of $2.62 million. The enterprise value is $2.00 million.
Important Dates
The next estimated earnings date is Friday, April 11, 2025, before market open.
Earnings Date | Apr 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PBM has 4.43 million shares outstanding. The number of shares has increased by 239.30% in one year.
Current Share Class | 4.43M |
Shares Outstanding | 4.43M |
Shares Change (YoY) | +239.30% |
Shares Change (QoQ) | +19.96% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 10.71% |
Float | 3.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | -2.10 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.64
Current Ratio | 0.64 |
Quick Ratio | 0.59 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -110.20 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -137.78% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 256.66% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.30% in the last 52 weeks. The beta is -0.45, so PBM's price volatility has been lower than the market average.
Beta (5Y) | -0.45 |
52-Week Price Change | -99.30% |
50-Day Moving Average | 1.13 |
200-Day Moving Average | 12.54 |
Relative Strength Index (RSI) | 27.74 |
Average Volume (20 Days) | 98,936 |
Short Selling Information
The latest short interest is 194,421, so 4.39% of the outstanding shares have been sold short.
Short Interest | 194,421 |
Short Previous Month | 258,061 |
Short % of Shares Out | 4.39% |
Short % of Float | 5.88% |
Short Ratio (days to cover) | 0.42 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -3.22M |
Pretax Income | -37.27M |
Net Income | -46.59M |
EBITDA | n/a |
EBIT | -3.22M |
Earnings Per Share (EPS) | -$76.91 |
Full Income Statement Balance Sheet
The company has $1.93 million in cash and $1.30 million in debt, giving a net cash position of $631,374 or $0.14 per share.
Cash & Cash Equivalents | 1.93M |
Total Debt | 1.30M |
Net Cash | 631,374 |
Net Cash Per Share | $0.14 |
Equity (Book Value) | -1.26M |
Book Value Per Share | -2.07 |
Working Capital | -1.27M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$2.87 million and capital expenditures -$12,155, giving a free cash flow of -$2.89 million.
Operating Cash Flow | -2.87M |
Capital Expenditures | -12,155 |
Free Cash Flow | -2.89M |
FCF Per Share | -$0.65 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |